V. Ojetti

Catholic University of America

Health Outcomes Studied

• Improved Bowel Movement Frequency
• Reduced Abdominal Pain

Papers (8)

• 2024
  Gut Microbiome Implication and Modulation in the Management of Recurrent Urinary Tract Infection.10.3390/pathogens13121028
• 2023
  Probiotics, the Immune Response and Acute Appendicitis: A Review.10.3390/vaccines11071170
• 2022Primary author
  Randomized control trial on the efficacy of Limosilactobacillus reuteri ATCC PTA 4659 in reducing inflammatory markers in acute uncomplicated diverticulitis10.1097/MEG.0000000000002342
• 2021
  Microbiota and Probiotics: The Role of Limosilactobacillus Reuteri in Diverticulitis.10.3390/medicina57080802
• 2021
  Gut Microbiota and Acute Diverticulitis: Role of Probiotics in Management of This Delicate Pathophysiological Balance.10.3390/jpm11040298
• 2021
  Lactobacillus Reuteri DSM 17938 (Limosilactobacillus reuteri) in Diarrhea and Constipation: Two Sides of the Same Coin?10.3390/medicina57070643
• 2019
  Supplementation with Lactobacillus reuteri ATCC PTA 4659 in patients affected by acute uncomplicated diverticulitis: a randomized double-blind placebo controlled trial10.1007/s00384-019-03295-1
• 2014Primary author
  The effect of Lactobacillus reuteri supplementation in adults with chronic functional constipation: a randomized, double-blind, placebo-controlled trial.10.15403/jgld.2014.1121.234.elr